We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Myotonic dystrophy type I (DM1) is one of the most variable of all human disorders, with virtually all body systems affected in some way, and age at disease onset varies from fetal life to old age. The character of DM1-related excessive daytime sleepiness (EDS) is that of a persistent sleepiness unaffected by naps, the latter being long, unrefreshing and without any associated dream. This chapter presents the scores of DM1 patients with and without EDS on the eight Short-Form 36-item Health Survey subscales, a frequently used generic health-related quality of life (HRQoL) questionnaire. It describes the personality and cognitive characteristics of 200 DM1 patients with and without EDS. The chapter discusses the habitual sleep-wake schedule and sleep-related complaints of 200 DM1 patients with and without EDS. Sleep-disordered breathing (SDB), hypercapnia, and nocturnal desaturation are all frequent in DM1. Psychostimulant drugs are increasingly used to treat EDS in DM1.
This chapter briefly discusses the genetic underpinnings, physical features and natural history of Williams syndrome and Smith-Magenis syndrome, and the cognitive and behavioural characteristics associated with these conditions in childhood. It then explores their long-term course, their effects on adjustment in adulthood and implications for support and intervention for affected individuals across the life span. Williams syndrome is a developmental disorder involving the vascular, connective tissue and central nervous systems. Studies have highlighted a distinctive psychological profile, and unusual personality and behavioural characteristics that are associated with Williams syndrome that differentiate affected children from other groups with learning disabilities. Children with Smith-Magenis syndrome tend to pose severe management problems for their carers due to hyperactivity, aggressive outbursts, self-injurious behaviours and sleep disturbance. Parents' interventions have focused on keeping their children safe at night and attempting to minimize the sleep disruption caused by night-waking.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.